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Members of the Dickkopf (Dkk) family of secreted proteins are potent inhibitors of Wnt/h-catenin signaling. In this study we show that
Dkk1, -2, and -3 are expressed distally in the epithelium, while Kremen1, the needed co-receptor, is expressed throughout the epithelium of
the developing lung. Using TOPGAL mice [DasGupta, R., Fuchs, E., 1999. Multiple roles for activated LEF/TCF transcription complexes
during hair follicle development and differentiation. Development 126, 4557–4568] to monitor the Wnt pathway, we show that canonical
Wnt signaling is dynamic in the developing lung and is active throughout the epithelium and in the proximal smooth muscle cells (SMC)
until E12.5. However, from E13.5 onwards, TOPGAL activity is absent in the SMC and is markedly reduced in the distal epithelium
coinciding with the onset of Dkk-1 expression in the distal epithelium. To determine the role of Wnt signaling in early lung development,
E11.5 organ cultures were treated with recombinant DKK1. Treated lungs display impaired branching, characterized by failed cleft formation
and enlarged terminal buds, and show decreased a-smooth muscle actin (a-SMA) expression as well as defects in the formation of the
pulmonary vasculature. These defects coincide with a pattern of decreased fibronectin (FN) deposition. DKK1-induced morphogenetic
defects can be mimicked by inhibition of FN and overcome by addition of exogenous FN, suggesting an involvement of FN in Wnt-regulated
morphogenetic processes.
D 2004 Elsevier Inc. All rights reserved.
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Early embryonic lung development is characterized by a
succession of cycles of bud initiation, bud outgrowth, and
bud arrest. Lung formation starts at E9.5, with an out-
pocketing of the endoderm from the ventral foregut.
Initially, the two primary buds undergo repetitive outgrowth0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.09.023
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E-mail address: sbellusci@chla.usc.edu (S. Bellusci).and branch laterally and distally in a highly reproducible
pattern. They develop asymmetrically, so that in the mouse
the right bud gives rise to four lobes, whereas the left bud
gives rise to only one.
The differentiation process of the epithelium and
mesenchyme is tightly coordinated with the branching
process. The most distal epithelial and mesenchymal cells
are essentially undifferentiated and as they leave the distal
domain, they differentiate progressively (Hogan, 1999). The
differentiation process is dependent upon the combination of
signals received. Experimental evidence is rapidly emerging
that the balance between activating and inhibitory signals is
a mechanism of fine regulation in development. For277 (2005) 316–331
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hog Interacting Protein (HIP), which binds to SHH and
prevents its binding to its receptor, Patched (PTC) (Chuang
et al., 2003). Similar inhibitory mechanisms exist between
Bone Morphogenetic Protein 4 and extracellular modulators
like Noggin, Gremlin, or Chordin (reviewed by Balemans
and Van Hul, 2002). In the Wnt pathway, secreted Frizzled-
related proteins (sFRP) and more recently Dickkopf (DKK)
are secreted molecules shown to inhibit Wnt signaling
(reviewed by Kawano and Kypta, 2003).
This work focuses on the role of DKK1 during lung
development. Through our study of DKK1, our goal is also to
investigate the role of the Wnt pathway during this process.
The Wnt growth factor family in the mouse is comprised of
19 different secreted ligands that interact with 10 known
seven-transmembrane receptors of the Frizzled (Fz) gene
family and either one of two single-span transmembrane
proteins, low-density-lipoprotein-receptor-related proteins
(LRP-5 and LRP-6) (Pinson et al., 2000; Tamai et al., 2000;
Wehrli et al., 2000). Historically, Wnt proteins have been
grouped into two classes, canonical and noncanonical.
Canonical Wnts bind to frizzled receptors, inhibiting
glycogen-synthase kinase-3h (GSK-3h)-mediated phosphor-
ylation of h-catenin. Hypophosphorylated h-catenin accu-
mulates in the cytoplasm, after which it translocates to the
nucleus, where it heterodimerizes with members of the TCF/
LEF transcription factor family to activate the transcription of
TCF/LEF target genes (reviewed by Seto and Bellen, 2004).
Noncanonical Wnts activate other Wnt signaling pathways,
such as the planar-cell-polarity (PCP)-like pathway that
guides cell movements during gastrulation (Heisenberg et
al., 2000). Activation of the PCP pathway can antagonize the
canonical pathway intracellularly (Ishitani et al., 2003; Kuhl
et al., 2001; Torres et al., 1996). SecretedWnt antagonists can
be divided into two functional classes, the secreted Frizzled-
related protein (sFRP) class and the Dickkopf class. Members
of the sFRP class bind directly to Wnts, thereby altering their
ability to bind to the Wnt receptor complex, while members
of the Dickkopf class inhibit Wnt signaling by binding to the
LRP5/LRP6 component of the Wnt receptor complex. In
addition to LRP5/6, DKK1 interacts with the high-affinity
DKK1 co-receptors Kremen1 (Krm1) or Kremen2 (Krm2),
which functionally cooperate with Dkk1 to block Wnt/beta-
catenin signaling (Mao et al., 2002 and reviewed by Kawano
andKypta, 2003). DKK1, DKK3, and DKK4 act as inhibitors
of canonicalWnt signaling, while DKK2 can function both as
an inhibitor in the presence of Kremen2 or as an activator in
its absence (Hoang et al., 2004; Mao and Niehrs, 2003).
Wnt signaling plays an important role in lung develop-
ment. Conditional inactivation of the b-catenin gene in the
epithelium of the developing mouse lung leads to neonatal
death resulting from severe lung defects (Mucenski et al.,
2003); branching of secondary bronchi is altered and the
number of small peripheral alveolar ducts and terminal
saccules is markedly reduced. In addition, the epithelium
fails to undergo proper distal differentiation, lacking theexpression of pro-SP-C protein and Vascular endothelial
growth factor-A (Vegf-A), the latter correlating with a
reduction in alveolar capillaries. So far, inactivation of only
two WNT ligands has resulted in lung defects. Wnt7b, a
canonical Wnt, is expressed in epithelial cells of the
peripheral lung. Wnt7b/ mice exhibit perinatal death
due to respiratory failure. Defects were observed in
proliferation of the lung mesenchyme resulting in lung
hypoplasia. In addition, Wnt7b/ embryos and newborn
mice exhibit severe defects in the smooth muscle compo-
nent of the major pulmonary vessels, with increased
apoptosis of the vascular smooth muscle cells (VSMCs),
resulting in rupture of the major blood vessels and
hemorrhages in the lungs after birth (Shu et al., 2002).
Wnt5a, a noncanonical Wnt, which is able to inhibit
canonical Wnt signaling (Topol et al., 2003; Westfall et
al., 2003), is expressed at high levels in the distal lung
mesenchyme. Wnt5a/ mice die perinatally from lung
defects including truncation of the trachea, overexpansion of
the peripheral airways, and delayed lung maturation.
Absence of Wnt5a activity in mutant lungs leads to
increased cell proliferation and up-regulation of the expres-
sion of Fgf10, Bmp4, Shh, and Ptc (Li et al., 2002).
To determine the role of canonical Wnt signaling in early
lung development, we treated E11.5 lung explants with
recombinant Dickkopf-1 (DKK1), a potent and specific
diffusible inhibitor of Wnt action that is also endogenously
secreted by the distal lung epithelium. We show that organ
cultures treated with DKK1 display impaired branching,
characterized by failed cleft formation and enlarged terminal
buds. DKK1-treated lung explants further show reduced a-
smooth muscle actin (a-SMA) expression and defects in the
formation of the pulmonary vascular network. These defects
coincide with a pattern of decreased fibronectin (FN)
deposition and Platelet-derived growth factor-A (Pdgf-a)
expression. DKK1-induced morphogenetic defects can be
mimicked by inhibition of FN and overcome by addition of
exogenous FN. Our findings suggest an intersection
between the Wnt and FN-integrin pathways and an involve-
ment of FN in Wnt-regulated morphogenetic processes.Materials and methods
Transgenic embryos
TOPGAL and Sp-C-GFP mice were a generous gift of
Dr. Elaine Fuchs and Dr. Jonathan Heath, respectively.
Flk1LacZ/+ mice were obtained from Jackson Laboratories.
All mice were bred in the C57BL6 background. Lungs were
isolated from embryonic day 11.5 (E11.5) embryos.
b-galactosidase staining
TOPGAL or Flk1LacZ/+ lungs at different developmental
stages (E11.5–E14.5) were dissected and fixed in 4%
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washed twice for 10 min in PBS at 48C, transferred into
freshly prepared X-gal solution, and stained at 378C until a
clear precipitate formed (Hogan et al., 1994). After rinsing
with PBS, lungs were post-fixed in 4% paraformaldehyde
in PBS. For vibratome sections, samples were embedded
in an albumin (300 mg/ml)–gelatin (5 mg/ml) mix, cross-
linked with glutaraldehyde (0.6%), and sectioned at 30 Am.
For microtome sections lungs were fixed in 4% parafor-
maldehyde, washed in PBS, dehydrated, and paraffin
embedded. Sections were stained with eosin for 2 s.
In situ hybridization
Microdissected and cultured lungs were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 2
h. They were washed twice with PBS, dehydrated over-
night in 70% ethanol at 48C, and stored in absolute
ethanol at 208C. The whole-mount in situ hybridization
protocol used was based on a previously described method
(Winnier et al., 1995). The following mouse cDNAs were
used as templates for the synthesis of digoxigenin-labeled
riboprobes: a 1.5-kb full-length mouse Bmp-4 (Winnier et
al., 1995), a 818-bp full-length Dkk1 and 1.4-kb Kremen1
and -2 probes (kindly provided by Dr. Christopher
Niehrs), a 991-bp Dkk2 fragment (cloned by RT-PCR
using primers Dkk2-F agttcttaagagtcccgagt and Dkk2-R
tacacaaattcacagtctgc), a 301-bp Dkk3 fragment (cloned by
RT-PCR using primers Dkk3-F cgtcctctgaggtgaacctggc and
Dkk3-R gtctcgggtgcatagcatctgc), a 800-bp Fz7, a 1-kb Fz8
(kindly provided by Dr. Jeremy Nathan), a 360-bp Lef1
probe (kindly provided by Dr. Rudolf Grosschedl), a 642-
bp Shh, a 630-bp Wnt-2A, a 360-bp Wnt5a, a 300-bp
Wnt7b (kindly provided by Dr. Andrew McMahon), a
900-bp Pdgf-a fragment (kindly provided by Dr. Linda
Karlsson), a 584-bp fragment of Fgf10 (Bellusci et al.,
1997), and a 2-kb LacZ probe (kindly provided by Dr.
Robert Kelly).
Organ culture
Isolated E11.5 lung explants removed on day 11.5
(E11.5) of gestation were placed on Nuclepore filters,
which were then laid on the surface of 800 Al DMEM/F12
medium containing 50 units/ml penicillin and 50 Ag/ml
streptomycin and 10% heat-inactivated fetal calf serum in
Nunclon dishes (technique adapted from Lebeche et al.,
1999). For some experiments illustrated in Figs. 9–11,
organ cultures were carried out in the absence of serum. No
difference was seen in overall growth, budding, or differ-
entiation of the lungs compared to lungs grown with serum.
We investigated the effects of DKK1 on these cultures by
adding 200 ng/ml of exogenous recombinant human DKK1
(R&D Systems). Dose response experiments (25, 50, 100,
200, and 400 ng/ml) were carried out. No response could
be seen at concentrations of DKK1 lower that 200 ng/ml.No differences were observed between 200 and 400 ng/ml.
The biological effect of an initial dose of DKK1 (added at
t = 0 h) on lung goes down with time. A peak in the
phenotype (essentially decreased cleft formation) is
obtained at 48 h and then the treated lung resumes a
development that is similar to the nontreated lung. After 96
h of culture, the treated and untreated lungs have the same
phenotype. However, a clear phenotype can be seen when
the medium gets refreshed with DKK1 (200 ng/ml) every 24
h. This suggests that recombinant DKK1 protein is very
unstable. Fibronectin was inhibited by adding anti-FN
antibody R745 diluted 1:50 to cultured E11.5 lung explants.
Rescue experiments were performed by adding human
plasma FN (2 mg/ml) dialyzed against DMEM/F12 to
DKK1 (200 ng/ml) treated cultures. Explants were cultured
for 3 days. Due to the limited stability of DKK1, fresh
DKK1 was added every day.
Immunohistochemistry
Cultured lungs (72 h) were fixed in 4% paraformalde-
hyde for 20 min, washed in PBS, dehydrated, and paraffin
embedded. Sections were treated with a monoclonal anti
a-smooth muscle actin antibody, clone 1A4, Cy3 con-
jugated (from SigmaR) at 1:200 and/or polyclonal anti h-
galactosidase antibody (from US Biological) at 1:200. Anti
Sp-C polyclonal antibody was used at dilution 1:1000
(a kind gift of Dr. Jeffrey Whitsett). All slides were
mounted with DAPI containing VectashieldR and photo-
micrographs were taken.
RT-PCR
RNA was isolated from individual lung cultures grown
in the presence or absence of DKK1, using Trizol reagent
(Invitrogen) according to the manufacturer’s instructions.
PCR reactions were performed with a minimum number of
cycles. RNA concentration was determined by spectro-
photometry. cDNA was generated using Superscript first-
strand synthesis system for RT-PCR (Invitrogen) according
to the manufacturer’s instructions. Competitive RT-PCR
was performed for b-actin , Vegf-A , and Bmp4 as
previously described (Zhao et al., 1998) to determine the
effects of treatment on mRNA levels in the lungs. The
same primers were used to amplify both cDNA and
competitor for each gene of interest. A known amount of
competitor was added to products of reverse transcription.
Competitive PCR, using b-actin, was performed with all
samples to equalize the concentration of cDNA in differ-
ent samples.
Semiquantitative RT-PCR was used for the other genes
of interest. The number of cycles for the different PCR
reactions was chosen to be in the linear amplification
phase. Oligonucleotides used were Shh-F gtcttctacgtgatc-
gagac, Shh-R ctgcgagtaccagtggat (32 cycles); Fgf10-F
tgttttttgtcctctcctgggag, Fgf10-R ggatactgacacattgtgcctcag
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tttacactcacacttggtca (32 cycles); Bmp4-F tccatcacgaagaa-
catc, Bmp4-R tagtcgtgtgatgaggtg (30 cycles); Vegf-F
gtgatcaagttcatggacgtct, Vegf-R atctgcatggtgatgttgctct (30
cycles); b-actin-F, b-actin-R (28 cycles); Pdgf-a-F tcttgga-
gatagactccgta, Pdgf-a-R acctcacatctgtctcctc (30 cycles); b-
actin-F gctctagacttcgagcaggaga, b-actin-R gatcttcatggtgc-
tagg (28 cycles); LacZ-F gcatcgagctgggtaataagcgttggcaat
and LacZ-R gacaccgacacaactggtaatggtagcgac (30 cycles).
Proliferation study
Organ cultures were carried out in the presence of
bromodeoxyuridine (BrdU, Amersham Biosciences UK
Limited) (1:500) for 3 h. Cultured lungs were fixed in
4% paraformaldehyde for 20 min, dehydrated, and
paraffin embedded. The sections were then treated with
monoclonal anti-bromodeoxyuridine (Clone BU-1) RPN
202 as recommended by the manufacturer (Amersham
Biosciences). FITC-labeled anti-mouse secondary anti-
bodies were used. Vectashield with DAPI was used as
a mounting medium. The sections were then photomicro-
graphed. The labeled epithelial cells as well as the total
number of cells of the lungs per section, photomicro-
graphed at 20, were counted. Five fields of distal
epithelium were counted and between 50 and 80 cells
were counted per field. The percent of BrdU-labeled cells
is reported. Statistical analysis was performed using the
paired t test.
Cell death analysis
Cultured lungs (72 h) were fixed in 4% paraformalde-
hyde for 20 min, washed in PBS, dehydrated, and paraffin
embedded. The bIn situ cell death detection kit, fluo-
resceinQ for detection of apoptosis at single cell level,
based on labeling of DNA strand breaks (TUNEL
technology), from Roche Applied Science, was used per
standard instructions. All slides were mounted with DAPI
containing VectashieldR and photomicrographs were
taken. Statistical analysis was performed using the paired
t test.
Counting of peripheral lung buds and quantitation of
vasculogenesis
Lung explants were cultured for 72 h in the presence or
absence of either DKK1, an anti-FN antibody, or DKK1 +
FN. Peripheral lung buds were counted and statistical
analysis was performed using the paired t test. Meta-
morphk was used to quantify the surface corresponding to
the h-galactosidase staining (reported in % of the total lung
surface) in Flk1LacZ/+ lungs treated with DKK1, antibodies
against FN or DKK1 plus FN. Statistical analysis was
performed using a single factor ANOVA followed by the
Dunnett’s multiple comparison post-test.Results
Wnt signaling in early lung development
Whole-mount RNA in situ hybridizations for Wnt
ligands, receptors, and the Tcf/Lef1 transcription factors
were performed to determine the expression of some of the
mediators of Wnt signaling during lung development. In the
early mouse lung (at E12.5), Wnt7b is expressed in the lung
epithelium with a more intense expression distally (Fig. 1A
and Shu et al., 2002),Wnt2a is highly expressed in the distal
mesenchyme (Fig. 1B) and Wnt5a shows low expression in
the mesenchyme and epithelium and is highest around the
trachea and pharynx (Fig. 1C and Bellusci et al., 1996). Lef1
(Lymphoid enhancer factor 1) is highly expressed in the
distal mesenchyme and at lower levels throughout the
mesenchyme adjacent to the lung epithelium (Fig. 1D and
Tebar et al., 2001). Fz7 is expressed in the mesenchyme
with higher expression distally and shows weaker expres-
sion in the epithelium (Fig. 1E and data not shown). Fz8 is
highly expressed throughout the epithelium (Fig. 1F). Fz2,
3, and 6 are expressed both in the epithelium and
mesenchyme (data not shown). These expression patterns
suggest that Wnt signaling can originate from the epithelium
and mesenchyme and can target both tissues in an autocrine
and/or paracrine fashion.
TOPGAL mice, which carry a b-galactosidase gene
under the control of a LEF/TCF and h-catenin inducible
promoter (DasGupta and Fuchs, 1999), were used to
investigate where LEF/TCF transcription factor complexes
were activated during early lung development. From E10.5
until E12.5, TOPGAL activation occurred throughout the
epithelium and in the mesenchyme adjacent to the proximal
airways where the bronchial smooth muscle cells (SMC)
arise (Figs. 1G–J and Maretto et al., 2003). At E13.5 (data
not shown) and E14.5 (Figs. 1K,L), TOPGAL activity was
no longer detected in the mesenchyme (data not shown) and
the activity in the epithelium was now significantly reduced
distally concomitant with the onset of expression of Dkk1 in
the distal epithelium (Figs. 2A,B). Dkk1 (Figs. 2A,B) and
Dkk3 (Fig. 2E) expression in the distal epithelium starts at
E13.5 and E12.5, respectively, while Dkk2 (Figs. 2C,D)
expression in the epithelium starts as early as E11.5 and is
up-regulated distally at later stages. The expression of high-
affinity DKK1 co-receptors Kremen1 (Fig. 2F) and Kre-
men2 (expressed at lower level, data not shown), which
functionally cooperate with Dkk1 to block Wnt/h-catenin
signaling, is detected between E11.5 and E14.5 throughout
the epithelium.
DKK1 treatment inhibits canonical WNT signaling
TOPGAL transgenic mice were also used to test whether
exogenously supplied recombinant DKK1 protein in lung
explant cultures of E11.5 lungs would result in the inhibition
of canonical Wnt signaling. TOPGAL activity as shown by
Fig. 1. Wnt signaling and lung development. Whole-mount in situ hybridizations on E11.5 lungs (A–F) and TOPGAL activity in E10.5–14.5 lungs (G–L). (A)
Wnt7b is expressed in the lung epithelium with higher expression distally. (B) Wnt2a is highly expressed in the distal mesenchyme. (C) Wnt5a shows low
expression in the mesenchyme and epithelium and is highest around the pharynx and proximal trachea. (D) Lef1 is highly expressed in the distal mesenchyme
and in the mesenchyme adjacent to the pulmonary epithelium. (E) Fz7 is expressed in the mesenchyme with higher expression distally. (F) Fz8 is highly
expressed throughout the epithelium. (G, H) TOPGAL expression at E10.5 and E12.5 show activity of the Wnt pathway throughout the lung. (I) Vibratome
sections of the lung shown in H exhibit LacZ expression in the distal epithelium. (J) Microtome section through one of the first two bronchi shows additional
expression in the mesenchyme adjacent to the epithelium. (K–L) E14.5, TOPGAL expression is markedly reduced from the distal epithelial branches; this loss
of TOPGAL expression coincides with the onset and domain of expression of DKK1 (see Fig. 2).
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the distal epithelium of DKK1 treated organ cultures (Figs.
3B,D; n = 5) compared to controls (Figs. 3A,C). The
detection of remaining TOPGAL activity in the more
proximal epithelium of DKK1 treated organ cultures (Fig.
3B) is likely the result of the high stability of the h-
galactosidase protein. In support of this conclusion, whole-
mount in situ hybridization for LacZ was performed on lung
explants cultured for 72 h in the presence or absence of
DKK1. The expression of LacZ was not detected after 72 h
of culture in lung explants treated with DKK1 (Fig. 3F)
while control explants still showed expression throughout
the epithelium and in the proximal mesenchyme (Fig. 3E).
This data was confirmed by semiquantitative RT-PCR for
LacZ on RNA isolated from DKK1 treated and untreated
lung explants grown for 72 h (Fig. 7M).DKK1 treatment of lung explant cultures disrupts branching
Transgenic mice expressing green fluorescent protein
(GFP) under the control of the Sp-C (surfactant protein-C)
promoter (which at early developmental stages is uniformly
expressed in the distal epithelium) were used to study the
effect of exogenously supplied recombinant DKK1 protein
on branching morphogenesis in explant cultures of E11.5
lungs. The expression of GFP in the epithelium allowed us to
follow the growth and branching of the lung during culture
(Fig. 4). E11.5 Sp-C-GFP lung explants were cultured for 72
h in the presence or absence of 200 ng/ml of recombinant
DKK1. DKK1-treated lungs were not significantly different
in overall size compared to controls (compare Figs. 4A,E,I,M
with B,F,J,N). DKK1 treatment resulted in decreased
branching characterized by a defect in cleft formation and
Fig. 2. Dkk expression in the lung epithelium. Gene expression was detected by whole-mount in situ hybridization on lungs at different gestational stages.
(A–B) Dkk1 is expressed from E13.5 on in the distal epithelium. (C) Dkk2 is expressed in the lung epithelium at E11.5 and is (D) up-regulated distally at
later stages (shown here at E15.5). At E12.5, Dkk3 is expressed in the distal epithelium (E). At E11.5, Kremen1 is expressed throughout the epithelium (F).
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lungs had an average of 24.4F 3.2 peripheral buds compared
to control lungs which had 34.4 F 3.1 (P V 0.0001, n = 5),
resulting in a decrease in branching of 29%. Defects in
branching started to appear after 48 h (compare Figs. 4I,K
with J,L) in culture and were very obvious after 72 h of
culture in the presence of DKK1 (Figs. 4N,P) as compared to
control lungs (Figs. 4M,O). Interestingly, these defects in
branching morphogenesis are not associated with defects in
proliferation. Proliferation rates, assessed by BrdU incorpo-
ration, in the epithelium of DKK1-treated lungs vs. control
lungs, were not significantly different (36 F 9% and 40 F
9%, respectively, n = 5, P = 0.2). At the same time, no
significant difference in apoptosis could be seen between
lung explants treated with DKK1 vs. control lungs (6.9F 1%
and 5.3 F 1%, respectively, n = 7, P = 0.05).
Fibronectin deposition is decreased in DKK1-treated lung
explants
In order to better define the observed defects in
branching morphogenesis, we analyzed the deposition ofFN, a protein previously described to be downstream of
Wnt signaling in Xenopus (Gradl et al., 1999) and the
perturbation of which leads to defects in branching in
embryonic salivary glands, lung, and kidney (Sakai et al.,
2003). The deposition of FN was therefore investigated by
immunohistochemistry on DKK1-treated and control lung
explants and was found to be markedly decreased in both
the epithelial basement membrane and the mesenchyme
of the DKK1-treated lung explants after 72 h of culture
(Fig. 5, n = 4).
DKK1 treatment perturbs differentiation of the mesenchyme
At E12.5, TOPGAL activity is present in the mesen-
chyme around the bronchi (Fig. 6A). These cells are also
co-expressing a-SMA (Fig. 6B) and therefore represent
proximal bronchial SMC. These observations led us to
investigate whether DKK1 treatment of E11.5 lung
explants would result in aberrant smooth muscle cell
differentiation. E11.5 lung explants were cultured up to 72
h in the presence or absence of DKK1. In control lungs,
a-SMA is detected at high levels around the bronchi and
Fig. 3. DKK1 treatment inhibits canonical WNT signaling. Lungs isolated from E11.5 TOPGAL transgenic mice were grown in culture for 72 h in the presence
(B, D) or absence (A, C) of recombinant DKK1 (200 ng/ml). TOPGAL activity was analyzed by h-gal staining. TOPGAL activity is reduced in DKK1-treated
lungs distally (B, D) compared to control (A, C). LacZ expression was detected by whole-mount in situ hybridization on TOPGAL lung explants isolated from
E11.5 WT mice and grown in culture for 72 h in the presence (F) or absence (E) of recombinant DKK1 (200 ng/ml). Under our conditions, LacZ expression is
not detected in DKK1-treated lung explants (F) vs. control (E).
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DKK1-treated lung explants, further distal expression of
a-SMA was severely impaired (Figs. 6D,F; n = 10). a-
SMA expression was mostly detected proximally in
DKK1-treated lung explants as early as 24 h after
treatment (data not shown). Interestingly, no differences
could be found in Sp-C expression in the epithelium in
untreated vs. DKK1-treated lung explants (data not shown,
n = 4). This result suggests that in our experimental
conditions, the proximal–distal differentiation of the lung
epithelium is not dramatically affected.
DKK1 treatment results in a decrease in Pdgf-a and Wnt2a
expression
Because of the observed defects in branching, whole-
mount in situ hybridization after 72 h of culturing in the
presence or absence of DKK1 was carried out to determinethe expression of key regulatory molecules in lung morpho-
genesis. The expression pattern of Pdgf-a was studied be-
cause of its known role in myofibroblast progenitor
proliferation and differentiation (Lindahl et al., 1997).
Pdgf-a expression was markedly reduced in lung explants
grown in the presence of DKK1 (Fig. 7B) compared to
control lungs (Fig. 7A, n = 3). Further, to test whether
DKK1 could be involved in a feedback loop with canonical
Wnts expressed distally in the lung, the expression pattern
of Wnt2a was studied by whole-mount in situ hybridization.
Wnt2a was markedly reduced in the distal mesenchyme in
lung explants grown in the presence of DKK1 (Fig. 7D)
compared to control lungs (Fig. 7C; n = 3). No differences
could be detected in the expression of Fgf10 (Figs. 7F,E),
Bmp4 (Figs. 7H,G), or Shh (Figs. 7J,I). This data was
confirmed by competitive and/or semiquantitative RT-PCR
on RNA isolated from DKK1-treated and untreated lung
explants grown for 72 h (Fig. 7M).
Fig. 4. DKK1 treatment disrupts branching morphogenesis. Lungs isolated from E11.5 Sp-C-GFP transgenic mice were grown in culture for 72 h in the
presence (B, D, F, H, J, L, N, P) or absence (A, C, E, G, I, K, M, O) of recombinant DKK1 (200 ng/ml), and branching morphogenesis was examined at 24-h
time intervals. E11.5 Sp-C GFP lung explants with similar numbers of buds were selected (A–D). After 24 h, no obvious differences in branching could be
detected (E–H). After 48 h, branching was clearly decreased (arrows) in the DKK1-treated cultures (J, L) compared to controls (I, K). By 72 h, DKK1-treated
organ cultures (N, P) showed markedly enlarged terminal buds vs. controls (M, O).
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To study the effect of DKK1 on vasculogenesis in the
lung, lungs isolated from E11.5 Flk1LacZ/+ mice were
cultured in the presence or absence of exogenous recombi-
nant DKK1. Flk1LacZ/+ mice exhibit b-galactosidase
expression in endothelial cells under the control of the
Flk1 promoter (Shalaby et al., 1995). h-gal staining
illustrates abnormal vessel formation in DKK1 treated
explants: Blood vessels are thinner, show reduced sprouting
from preexisting vessels (angiogenesis), and impaired
formation of large vessels and establishment of intercon-
nections (Figs. 8C,D), compared to untreated lung explants
(Figs. 8A,B; n = 3). Quantification of the surface
corresponding to the h-galactosidase staining, reported in
percentage of the total lung surface, shows a significantdifference between control and DKK1-treated lung explants
(3.3 F 1.1% vs. 1.5 F 0.7%, respectively, P b 0.05). This
defect occurs without a decrease in Vegf-a expression based
on competitive RT-PCR results (Fig. 7M).
Inhibition of FN activity recapitulates DKK1 defects in the
lung
A polyclonal anti-FN antibody was used to inhibit cleft
formation and branching in the lung as described by Sakai
et al. (2003). Treatment with an anti-FN antibody
significantly inhibited branching (Figs. 9A,B) of the lung
explants. Lung explants treated with an anti-FN antibody
had an average of 15.6 F 4.6 peripheral buds compared to
control lungs which had an average of 35.4 F 2.4 (P V
0.0001, n = 7) peripheral lung buds, resulting in a
Fig. 5. Fibronectin expression is decreased in DKK1-treated lungs. Lungs isolated from E11.5 wild-type mice where grown in culture for 72 h in the presence
(B, D) or absence (A, C) of recombinant DKK1 (200 ng/ml). Fibronectin expression was analyzed by immunohistochemistry on sections. (A, C) Fibronectin is
present in the basement membrane around the epithelium (arrowheads) and in the mesenchyme at sites of cleft formation (arrows). (B, D) Fibronectin
deposition by the epithelium (arrowheads) into the basement membrane and at sites of cleft formation (arrows) is reduced upon DKK1 treatment. Experimental
conditions and photography (exposure time) were identical between control and DKK1-treated lungs to allow for direct comparison of FN expression. The
exposure time was chosen so that the maximum signal (i.e., for CTRL) was below the saturation point of the camera.
Fig. 6. DKK1 reduces SMA expression in the mesenchyme. (A) h-gal (green) immunohistochemistry on sections of E12.5 TOPGAL lungs show TOPGAL
activity in the epithelium and the proximal SMC (arrows). (B) Co-immunostaining of h-gal (green) and SMA (red) (arrows) (on sections) in the proximal SMC
around the upper respiratory airways. Lungs isolated from E11.5 WT mice were grown in culture for 72 h in the presence (D, F) or absence (C, E) of
recombinant DKK1 (200 ng/ml). a-Smooth muscle actin (SMA) expression was analyzed by immunohistochemistry (red); nuclei were stained with DAPI
(blue). (C, E) In the untreated lung explants, the expression of SMA is found in the bronchial SMC around the airways. (D, F) In DKK1-treated lung explants,
SMA expression did not expand in spite of lung growth, and very little SMA expression can be detected more distally around the airways. Experimental
conditions and photography (exposure time) were identical between control and DKK1 treated lungs to allow for direct comparison of a-SMA expression. The
exposure time was chosen so that the maximum signal (i.e., for CTRL) was below the saturation point of the camera.
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antibody further reduced smooth muscle differentiation
around the airways (Figs. 9C,D) and perturbed proper lung
vascular network formation (Figs. 8E,F), recapitulating the
defects seen after treatment with DKK1. Quantification of
the surface corresponding to the h-galactosidase staining
shows a significant difference between control and lung
explants treated with antibodies against FN (3.3 F 1.1%
vs. 1.0 F 0.2%, respectively, P b 0.05). However, Pdgf-a
expression was unchanged in lung explants grown in the
presence of an anti-FN antibody (Fig. 7L) compared to
control lungs (Fig. 7K, n = 3).
Exogenously supplied FN rescues the DKK1 phenotype
Exogenous FN (2 mg/ml) (Sakai et al., 2003) was added
to DKK1-treated organ cultures to replace the FN depleted
by DKK1 treatment. Experimental supplementation of FN
successfully rescued branching morphogenesis (Figs. 10I,J)
compared to organ cultures treated with DKK1 alone (Figs.
10E–H) and control lungs (Figs. 10A–D). While DKK1-
treated lungs responded as previously described (Fig. 4), no
significant difference in number of peripheral buds could be
found between control lung explants (29 F 2.4) and lung
explants treated with DKK1+FN (29.4 F 2.5) (P = 0.3786,
n = 5). Addition of exogenous FN to DKK1-treated lung
explants did not rescue the loss of TOPGAL (Fig. 10L)
activity compared to control lungs (Fig. 10K), indicating
that the inhibitory effect of DKK1 on canonical Wnt
signaling was not affected and that FN is acting downstream
of DKK1. Further, exogenously supplied FN not only
rescued but enhanced a-SMA expression distally in DKK1-
treated lung explants (Figs. 11E,F, n = 3) compared to,
respectively, lung explants treated with DKK1 alone (Figs.
11C,D), or untreated control explants (Figs. 11A,B). Close
examination of the distal portion of the lungs showed that,
while in control lungs, the expression of a-SMA is found in
the SMC around the bronchi but excluded from the tip (Fig.
11B); FN treatment (in presence of DKK1) resulted in an
expansion of the a-SMA expression domain more distally
(Fig. 11F). Application of exogenous FN to DKK1-treated
lung explants also partially rescued vascular network defects
(Figs. 8G,H; n = 3). Quantification of the surface
corresponding to the h-galactosidase staining shows no
significant difference between control and lung explants
treated simultaneously with DKK1 and FN (3.3 F 1.1% vs.
3.3 F 0.6%, respectively, P b 0.05).Discussion
Careful analysis of TOPGAL mice showed that canonical
Wnt signaling in the lung is dynamic. From E10.5 until
E12.5, TOPGAL activation occurred throughout the epi-
thelium and in the proximal SMC. However, from E13.5
onwards, TOPGAL activity was only detected in theepithelium but was reduced distally, concomitant with the
onset of expression of Dkk1 in the distal epithelium. To
determine the role of canonical Wnt signaling in early lung
development, we treated E11.5 lung explants in vitro with
recombinant DKK1, a potent and specific diffusible
inhibitor of Wnt action that is also endogenously secreted
by the lung epithelium. We used TOPGAL, Sp-C-GFP and
Flk1LacZ/+ mice, respectively, to show that DKK1 treatment
of lung explants inhibited canonical Wnt signaling, impaired
branching and resulted in defects in the formation of the
pulmonary vascular network. The DKK1-treated lungs
further displayed a reduction in a-SMA expression around
the bronchi. These defects coincided with a pattern of
decreased FN deposition. We further observed a reduction in
Wnt2a and Pdgf-a expression. However, no difference in
expression could be detected for the major lung morphogens
Fgf10, Shh, and Bmp4, nor Vegf, and no significant
differences in proliferation of the epithelium could be
found. Inhibition of FN activity with an anti-FN antibody
recapitulated the DKK1 imposed morphogenetic defects in
the lung whereas exogenously supplied FN rescued the
DKK1 phenotype.
Wnt signaling in early lung development
In the embryonic lung, Wnt ligands, Wnt receptors, and
associated Wnt transcription factors are detected from very
early stages of development in the epithelium and mesen-
chyme, suggesting thatWnt signaling can occur in both tissue
compartments. However, our results using TOPGAL mice
show that Wnt signaling occurs mostly in the epithelium and
additionally in the mesenchymal cells directly apposed to the
proximal bronchi (Fig. 1 and Maretto et al., 2003). The
mesenchymal TOPGAL-positive cells in the lung also
express a-SMA, indicating that differentiated SMC around
the proximal airways are responding to Wnt signaling (Fig.
6). TOPGAL mice have previously been shown to be
excellent reporters for Wnt signaling (DasGupta and Fuchs,
1999) and in vivo overexpression in the distal lung epithelium
of the noncanonical Wnt5a, which blocks canonical Wnt
signaling, leads to a decrease in TOPGAL activity (Dr. C. Li,
personal communication).
Wnt signaling is modulated by secreted antagonists, like
secreted Frizzled-related proteins (sFrp) and members of the
Dickkopf family. We show herein that the expression of
Dickkopf-1, -2, and -3 in the distal epithelium of the lung
starts from E13.5, E11.5, and E12.5, respectively (Fig. 2).
The onset of Dkk1 expression correlates with the reduction
of TOPGAL activity in the distal epithelium from E13.5
onwards. Interestingly, Dkk1/ mice have no lung pheno-
type (Mukhopadhyay et al., 2001 and Westphal personal
communication). This suggests that the expression of Dkk1,
Dkk2, and Dkk3 (Fig. 2) in the distal epithelium is
redundant.
Transgenic experiments in mouse have shown that
Dkk1 overexpression inhibits canonical Wnt signaling.
S.P. De Langhe et al. / Developmental Biology 277 (2005) 316–331326Ectopically expressed Dkk1 under the control of a keratin-
14 promoter, which directs transgene expression to the
surface epithelium and to the basal cells of the epidermis
during embryogenesis, resulted in a complete failure of
hair follicle placode formation and blocked tooth andmammary gland development before the bud stage (Andl
et al., 2002). Transgenic mice ectopically expressing Dkk1
in the gut epithelium showed a loss of intestinal crypts,
and disrupted intestinal homeostasis (Pinto et al., 2003).
Adenoviral expression of Dkk1 in both the small intestine
Fig. 8. DKK1 reduces vascular development. Lungs isolated from E11.5 Flk1LacZ/+ mice were grown in culture for 72 h in the presence of DKK1 (C, D), FN
Ab (E, F), DKK1 + FN (G, H) or in absence of all those (A, B). Vasculogenesis was analyzed by h-gal staining. Note the abnormal vessel formation, thinner
blood vessels, reduced sprouting from pre-existing vessels (angiogenesis), and impaired formation of large vessels and establishment of interconnections in
lungs treated with DKK1 (C, D) or FN Ab compared to control (A, B). Application of exogenous FN to DKK1-treated lung explants (G, H) partially rescued
the vascular network defects seen when treated with DKK1 alone (C, D) compared to control lungs (A, B).
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accompanied by progressive architectural degeneration
with the loss of crypts, villi, and glandular structure
(Kuhnert et al., 2004). Here, we treated lung explants from
TOPGAL embryos with recombinant DKK1 protein and
our results show a marked decrease in TOPGAL activity,
indicating that we could inhibit canonical Wnt signaling in
the lung (Fig. 3).
Decreased FN deposition perturbs branching, smooth
muscle differentiation, and formation of the lung
vasculature
The extracellular matrix (ECM) protein FN has been
shown to be essential for cleft formation during the initiation
of epithelial branching in several organ systems including
the lung (Gill et al., 2003; Sakai et al., 2003). Fibronectin is
secreted by the lung epithelium as part of the basement
membrane and has been shown to be a Wnt target gene in
Xenopus (Gradl et al., 1999). Our results suggest that the
decrease in FN deposition by the lung epithelium in
response to DKK1 treatment (Fig. 5) is the primary cause
for decreased branching of the epithelium (Fig. 4). Interest-
ingly, the observed defect in branching seemed mainly to be
associated with the ECM defect as no differences in
epithelial proliferation could be found (data not shown),
as well as no changes in the expression of key morphoge-Fig. 7. Gene expression analysis in DKK1-treated lungs. Gene expression was de
E11.5 WT mice and grown in culture for 72 h in the presence (B, D, F, H, J) or
expression is strongly reduced in DKK1 treated lung explants (B) vs. control (A).
(D) vs. control (C). No differences could be detected in the expression of Fgf10
expression of Pdgf-a in lung explants treated with an anti-FN antibody (L) compa
semiquantitative RT-PCR (for LacZ, Wnt2a, Pdgf-A, Shh, and Fgf10) on RNA is
shows a reduction in LacZ, Pdgf-a, andWnt2a expression in DKK1-treated lungs v
was unchanged. Competitive PCR, using b-actin, was performed on all samples
fragments are 100 bp larger in size than product of interest.netic genes such as Fgf10, Shh, and Bmp4 could be detected
(Fig. 7). Moreover, the branching defects induced by DKK1
could be recapitulated by treating lung explants with a
blocking anti-FN antibody (Fig. 9) and could be rescued by
co-treatment with exogenous FN (Fig. 10).
We also demonstrated that DKK1 treatment perturbed
expression of a-SMA, a terminal marker of smooth muscle
differentiation. This result also was associated with the
decrease in FN expression, as treatment of lung explants
with a blocking anti-FN antibody reduced a-SMA expres-
sion around the bronchi (Fig. 9). Previously, it has been
shown that the differentiation of lung embryonic mesen-
chymal cells into SMC is triggered by their spreading along
the airway basement membrane. Blocking of basement
membrane assembly prevented mesenchymal cell spreading
and smooth muscle differentiation (Yang et al., 1998).
Further evidence for this was found when we studied a-
SMA expression in DKK1 treated lung explants that were
co-treated with exogenous FN. Treatment with exogenous
FN led to an increase in a-SMA expression around the
bronchi, which was even further expanded distally com-
pared to control lung explants (Fig. 11), suggesting
premature differentiation of the SMC.
Our results indicate that Wnt signaling is not likely to
play a direct role in the differentiation of the distal
mesenchyme into bronchial SMC, because TOPGAL
activity could not be found in the mesenchyme adjacenttected by whole-mount in situ hybridization on lung explants isolated from
absence (A, C, E, G, I) of recombinant DKK1 (200 ng/ml). (A, B) Pdgf-a
(C, D) Wnt2a expression is severely reduced in DKK1 treated lung explants
(F, E), Bmp4 (H, G), or Shh (J, I). No difference could be detected in the
red to controls (K). Competitive RT-PCR (for Vegf, Bmp4, and h-actin) and
olated from DKK1-treated and untreated lung explants grown for 72 h (M)
s. control, while the expression of Fgf10, Shh, Bmp4, and Vegf-a expression
to equalize the concentration of cDNA in different samples. Competitor
Fig. 9. Inhibition of FN recapitulates DKK1 defects in the lung. (A, B) Phase contrast images of living E11.5 (inset 0 h) lung explants cultured for 72 h
with (B) or without (A) anti-FN R745 antibody diluted 1:50. Treated lung explants showed a marked decrease in branching (B) compared to nontreated
(A). (C, D) a-Smooth muscle actin (SMA) expression was analyzed by immunohistochemistry (red); nuclei were stained with DAPI (blue). (C) In the
untreated lung explants, the expression of SMA is found in the bronchial SMC around the airways. (D) In anti-FN-treated lung explants, SMA expression
was reduced more distally around the airways. Experimental conditions and photography (exposure time) were identical between control and DKK-1-
treated lungs to allow for direct comparison of a-SMA expression. The exposure time was chosen so that the maximum signal (i.e., for CTRL) was below
the saturation point of the camera.
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developmental time frame of our organ cultures. Rather,
we hypothesize that blocking Wnt signaling in the distalFig. 10. Exogenously supplied FN rescues branching in DKK1-treated lung explan
treatment with PBS control in the absence (A, B) or presence (C, D) of 10% fetal b
bovine serum (G, H); or DKK1 (200 ng/ml) plus FN (2 mg/ml) (I, J). FN treatm
isolated from E11.5 TOPGAL transgenic mice were grown in culture for 72 h in
TOPGAL activity was analyzed by LacZ in situ hybridization and was reduced iepithelium results in a decrease of FN deposition by the
epithelium. This would lead to a defective epithelial matrix
and basement membrane, which is necessary for thets. (A–J) Phase contrast images of E11.5 lung explants cultured for 72 h after
ovine serum; DKK1 (200 ng/ml) in the absence (E, F) or presence of 10 fetal
ent rescued branching defects in DKK1 treated lung explants (I, J). Lungs
the presence (L) or absence (K) of DKK1 (200 ng/ml) plus FN (2 mg/ml).
n DKK1-treated lungs in the presence of FN (L) compared to control (K).
Fig. 11. Exogenously supplied FN rescues and enhances a-SMA expression in DKK1-treated lung explants. Lungs isolated from E11.5 WT mice were grown
in culture for 72 h in the presence of DKK1 (200 ng/ml) (C, D) or DKK1 (200 ng/ml) and FN (2 mg/ml) (E, F) or in absence of those (A, B). a-SMA
expression was analyzed by immunohistochemistry (red); nuclei were stained with DAPI (blue). (A, B) In the untreated lung explants, the expression of a-
SMA is found in the bronchial SMC around the bronchi. (C, D) In DKK1-treated lung explants, a-SMA expression did not expand in spite of clear lung growth
and very little a-SMA expression can be detected more distally around the bronchi. (E, F) In lungs treated with DKK1 (200 ng/ml) and FN (2 mg/ml),
enhanced a-SMA staining was detected and a-SMA expression was clearly expanded distally around the bronchi. Experimental conditions and photography
(exposure time) were identical between control and treated lungs to allow for direct comparison of a-SMA expression. The exposure time was chosen so that
the maximum signal (i.e. for DKK1 + FN) was below the saturation point of the camera.
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differentiation. Interestingly, increased deposition of FN
into the subepithelial space of the airways is observed in
all forms of asthma and occurs early in the progression of
the disease (Hocking, 2002). Asthma is also characterized
by an increase in the number of bronchial SMC. FN is
capable of inducing a-smooth muscle actin expression and
promotes the differentiation of SMC in vitro (Thannickal
et al., 2003).
Interestingly, no significant defect could be found in
differentiation of the proximal SMC (evaluated by main-
tenance of a-SMA expression) that had already differ-
entiated in E11.5 lungs before the start of DKK1 treatment.
TOPGAL activity could be found in the proximal SMC until
E12.5 in vivo (Figs. 1 and 6). This raises a question about
the role of Wnt signaling in these proximal SMC. One
possibility is that Wnt signaling is already switched off at
E12.5 and that the presence of TOPGAL activity is due to
the high stability of the h-galactosidase protein. This would
indicate that Wnt signaling is directly involved in the
differentiation of the proximal bronchial SMC. A second,
less likely, possibility would be that the Wnt signaling in the
proximal SMC is necessary for maintenance of their
differentiation. However, we were not able to address this
possibility because lungs isolated before E11.5 do not
develop well in vitro. Deleting b-catenin specifically in the
SMC in vivo should therefore be very informative.
Inhibition of canonical Wnt signaling further perturbed
the proper formation of the lung vasculature, probably
through the down regulation of FN deposition, as sproutingof blood vessels (angiogenesis) is mediated by a5h1
integrins through their binding to FN (Kim et al., 2000a,b,
2002). Indeed, similar defects in the lung vasculature were
obtained after treatment of lung explants with a blocking
anti-FN antibody (Fig. 8), and defects induced by treatment
with DKK1 could partially be rescued by co-treating lung
explants with exogenous FN (Fig. 8). We cannot exclude
that there could also be a direct effect of Wnt signaling on
the formation of the lung vasculature, sinceWnt2a is needed
for proper placental vascularization, although Wnt2a/
mice did not have an abnormal lung phenotype (Monkley et
al., 1996).
Possible functions for Wnt signaling in the epithelium
The exact functions of Wnt signaling are still contro-
versial. The present consensus about Wnt signaling during
development is that the Wnt pathway is critical for
progenitor cell proliferation and/or lineage differentiation
and is involved in maintaining progenitor cells in an
undifferentiated state and possibly maintaining the differ-
entiation of fully matured cells (Batlle et al., 2002; Huelsken
et al., 2001; Merrill et al., 2001; Pinto et al., 2003; Reya et
al., 2003, reviewed in Alonso and Fuchs, 2003).
b-catenin inactivation in the distal epithelium leads to a
smaller proximalized lung. This indicates that Wnt signaling
is probably not critical for the development of the proximal
airway, but rather is necessary to prevent premature differ-
entiation of the distal epithelium. Supporting this idea is that
inactivating b-catenin in the proximal conducting airways
S.P. De Langhe et al. / Developmental Biology 277 (2005) 316–331330using the CCSP promoter (which is active only from E14
onwards) does not perturb lung development (Mucenski et
al., 2003). Expression of a constitutively active h-catenin–
LEF1 fusion protein in transgenic embryo’s using the lung-
endoderm-specific Sp-C promoter lead to an accumulation
of proliferating epithelial cells that do not express morpho-
logical or molecular features of differentiated lung epithelial
lineages. High levels of Wnt signaling in lung epithelium
inhibited the terminal differentiation of pulmonary specific
epithelial cell types, as judged by cell morphology and gene
expression (Okubo and Hogan, 2004).
We hypothesize that the distal portion of the embryonic
lung can be considered to be a reservoir of epithelial and
mesenchymal progenitor cells. TOPGAL activation from
E9.5 up to E12.5 in the most distal part of the lung suggests
that Wnt signaling is instrumental to prevent premature
differentiation.
Our results further indicate that canonical Wnt signaling
is inhibited in the distal epithelium from E13.5 onwards. It
is possible that this inhibition coincides with the entry of the
progenitor cells into a differentiation pathway. The window
of time between E10.5 and E14.5 is also critical for FGF
signaling, to allow the survival and expansion of the
precursor cells at the tip (Hokuto et al., 2003). It is therefore
likely that perturbation of the FGF or Wnt pathway during
this time frame will result in a reduction or loss of these
progenitors, causing severe defects in subsequent lung
development.
In conclusion, our results provide new insights into the
function of Wnt signaling during early lung development.
Further studies will be needed to elucidate the role of Wnt
signaling during later stages of lung development and in
tissue repair after injury.Acknowledgments
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